nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—HTR2A—cerebellar cortex—hypothyroidism	0.0618	0.09	CbGeAlD
Minaprine—DRD1—nerve—hypothyroidism	0.0581	0.0846	CbGeAlD
Minaprine—MAOA—nerve—hypothyroidism	0.0347	0.0506	CbGeAlD
Minaprine—DRD2—nerve—hypothyroidism	0.0344	0.05	CbGeAlD
Minaprine—HTR2A—urine—hypothyroidism	0.0328	0.0478	CbGeAlD
Minaprine—CYP2D6—urine—hypothyroidism	0.0299	0.0435	CbGeAlD
Minaprine—ACHE—heart—hypothyroidism	0.0235	0.0343	CbGeAlD
Minaprine—HTR2A—nerve—hypothyroidism	0.0227	0.033	CbGeAlD
Minaprine—ACHE—adrenal gland—hypothyroidism	0.0176	0.0256	CbGeAlD
Minaprine—ACHE—thyroid gland—hypothyroidism	0.017	0.0247	CbGeAlD
Minaprine—HTR2B—adrenal cortex—hypothyroidism	0.0163	0.0237	CbGeAlD
Minaprine—HTR2B—heart—hypothyroidism	0.0158	0.0229	CbGeAlD
Minaprine—CHRM1—cardiovascular system—hypothyroidism	0.0149	0.0218	CbGeAlD
Minaprine—HTR2B—cardiovascular system—hypothyroidism	0.0149	0.0216	CbGeAlD
Minaprine—ACHE—testis—hypothyroidism	0.0145	0.0211	CbGeAlD
Minaprine—ACHE—cerebellum—hypothyroidism	0.0134	0.0195	CbGeAlD
Minaprine—MAOA—adrenal cortex—hypothyroidism	0.0133	0.0194	CbGeAlD
Minaprine—MAOA—heart—hypothyroidism	0.0129	0.0188	CbGeAlD
Minaprine—MAOA—cardiovascular system—hypothyroidism	0.0122	0.0177	CbGeAlD
Minaprine—SLC6A4—blood—hypothyroidism	0.0119	0.0173	CbGeAlD
Minaprine—HTR2B—adrenal gland—hypothyroidism	0.0118	0.0171	CbGeAlD
Minaprine—HTR2B—blood—hypothyroidism	0.0118	0.0171	CbGeAlD
Minaprine—HTR2B—thyroid gland—hypothyroidism	0.0113	0.0165	CbGeAlD
Minaprine—MAOA—pituitary gland—hypothyroidism	0.0108	0.0157	CbGeAlD
Minaprine—DRD2—pituitary gland—hypothyroidism	0.0107	0.0155	CbGeAlD
Minaprine—MAOA—adrenal gland—hypothyroidism	0.00962	0.014	CbGeAlD
Minaprine—MAOA—blood—hypothyroidism	0.00962	0.014	CbGeAlD
Minaprine—MAOA—thyroid gland—hypothyroidism	0.00929	0.0135	CbGeAlD
Minaprine—MAOA—female gonad—hypothyroidism	0.00897	0.0131	CbGeAlD
Minaprine—HTR2A—heart—hypothyroidism	0.00841	0.0122	CbGeAlD
Minaprine—MAOA—testis—hypothyroidism	0.00796	0.0116	CbGeAlD
Minaprine—HTR2A—cardiovascular system—hypothyroidism	0.00794	0.0116	CbGeAlD
Minaprine—DRD2—testis—hypothyroidism	0.00787	0.0115	CbGeAlD
Minaprine—MAOA—liver—hypothyroidism	0.00752	0.011	CbGeAlD
Minaprine—MAOA—cerebellum—hypothyroidism	0.00735	0.0107	CbGeAlD
Minaprine—DRD2—cerebellum—hypothyroidism	0.00727	0.0106	CbGeAlD
Minaprine—HTR2A—gonad—hypothyroidism	0.0072	0.0105	CbGeAlD
Minaprine—HTR2A—pituitary gland—hypothyroidism	0.00703	0.0102	CbGeAlD
Minaprine—HTR2A—adrenal gland—hypothyroidism	0.00628	0.00914	CbGeAlD
Minaprine—HTR2A—blood—hypothyroidism	0.00628	0.00914	CbGeAlD
Minaprine—CYP2D6—blood—hypothyroidism	0.00572	0.00832	CbGeAlD
Minaprine—CYP2D6—female gonad—hypothyroidism	0.00533	0.00776	CbGeAlD
Minaprine—HTR2A—testis—hypothyroidism	0.00519	0.00756	CbGeAlD
Minaprine—HTR2A—liver—hypothyroidism	0.00491	0.00715	CbGeAlD
Minaprine—HTR2A—cerebellum—hypothyroidism	0.0048	0.00698	CbGeAlD
Minaprine—CYP2D6—testis—hypothyroidism	0.00473	0.00689	CbGeAlD
Minaprine—CYP2D6—liver—hypothyroidism	0.00447	0.00651	CbGeAlD
Minaprine—CYP2D6—cerebellum—hypothyroidism	0.00437	0.00636	CbGeAlD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00189	0.00603	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00185	0.00591	CbGpPWpGaD
Minaprine—HTR2A—G alpha (q) signalling events—TRH—hypothyroidism	0.00183	0.00586	CbGpPWpGaD
Minaprine—CHRM1—G alpha (q) signalling events—TRH—hypothyroidism	0.00182	0.00583	CbGpPWpGaD
Minaprine—DRD1—G alpha (s) signalling events—AVP—hypothyroidism	0.0018	0.00576	CbGpPWpGaD
Minaprine—MAOA—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00175	0.00561	CbGpPWpGaD
Minaprine—ACHE—Peptide hormone metabolism—POMC—hypothyroidism	0.00174	0.00555	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.00174	0.00555	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00173	0.00554	CbGpPWpGaD
Minaprine—ACHE—Peptide hormone metabolism—IGF1—hypothyroidism	0.00167	0.00534	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00164	0.00524	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00163	0.00522	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00163	0.00521	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00155	0.00494	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00155	0.00494	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00152	0.00485	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—AVP—hypothyroidism	0.00151	0.00483	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00146	0.00466	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00146	0.00466	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.0014	0.00447	CbGpPWpGaD
Minaprine—HTR2B—G alpha (q) signalling events—AVP—hypothyroidism	0.00138	0.00439	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—TRH—hypothyroidism	0.00132	0.00422	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00125	0.00398	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00125	0.00398	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—TRH—hypothyroidism	0.00125	0.00398	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00123	0.00394	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00123	0.00393	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—AVP—hypothyroidism	0.00122	0.00391	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00121	0.00388	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00121	0.00386	CbGpPWpGaD
Minaprine—DRD1—G alpha (s) signalling events—POMC—hypothyroidism	0.0012	0.00382	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—TSHB—hypothyroidism	0.00118	0.00376	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—TSHR—hypothyroidism	0.00118	0.00376	CbGpPWpGaD
Minaprine—ACHE—Metabolism—IYD—hypothyroidism	0.00117	0.00373	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00111	0.00356	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—TSHB—hypothyroidism	0.00111	0.00355	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—TSHR—hypothyroidism	0.00111	0.00355	CbGpPWpGaD
Minaprine—HTR2C—G alpha (q) signalling events—AVP—hypothyroidism	0.00111	0.00354	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.0011	0.00351	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.0011	0.00351	CbGpPWpGaD
Minaprine—MAOA—Metabolism—IYD—hypothyroidism	0.0011	0.00351	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00108	0.00346	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00108	0.00346	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00108	0.00344	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00108	0.00344	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—TRH—hypothyroidism	0.00107	0.0034	CbGpPWpGaD
Minaprine—ACHE—Metabolism—ATP5O—hypothyroidism	0.000992	0.00317	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000992	0.00317	CbGpPWpGaD
Minaprine—HTR2A—G alpha (q) signalling events—AVP—hypothyroidism	0.000963	0.00308	CbGpPWpGaD
Minaprine—CHRM1—G alpha (q) signalling events—AVP—hypothyroidism	0.000958	0.00306	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—TSHB—hypothyroidism	0.000949	0.00303	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—TSHR—hypothyroidism	0.000949	0.00303	CbGpPWpGaD
Minaprine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000942	0.00301	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—TRH—hypothyroidism	0.00094	0.003	CbGpPWpGaD
Minaprine—MAOA—Metabolism—ATP5O—hypothyroidism	0.000935	0.00299	CbGpPWpGaD
Minaprine—ACHE—Metabolism—TPO—hypothyroidism	0.000933	0.00298	CbGpPWpGaD
Minaprine—MAOA—Biological oxidations—POMC—hypothyroidism	0.000932	0.00298	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—TRH—hypothyroidism	0.000925	0.00295	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—AVP—hypothyroidism	0.000924	0.00295	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—TRH—hypothyroidism	0.00092	0.00294	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000911	0.00291	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—AVP—hypothyroidism	0.000904	0.00289	CbGpPWpGaD
Minaprine—MAOA—Metabolism—TPO—hypothyroidism	0.000879	0.00281	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000875	0.0028	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000865	0.00276	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000862	0.00275	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000859	0.00274	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000857	0.00274	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—TSHB—hypothyroidism	0.000838	0.00268	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—TSHB—hypothyroidism	0.000838	0.00268	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—TSHR—hypothyroidism	0.000838	0.00268	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—TSHB—hypothyroidism	0.000824	0.00263	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—TSHR—hypothyroidism	0.000824	0.00263	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—TSHB—hypothyroidism	0.00082	0.00262	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—TSHR—hypothyroidism	0.00082	0.00262	CbGpPWpGaD
Minaprine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000764	0.00244	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—TRH—hypothyroidism	0.000746	0.00238	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000735	0.00235	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—TRH—hypothyroidism	0.000704	0.00225	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—AVP—hypothyroidism	0.000694	0.00222	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—TRH—hypothyroidism	0.000678	0.00216	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—TSHB—hypothyroidism	0.000665	0.00212	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—TSHR—hypothyroidism	0.000665	0.00212	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—AVP—hypothyroidism	0.000654	0.00209	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000648	0.00207	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—TRH—hypothyroidism	0.000639	0.00204	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000638	0.00204	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000635	0.00203	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—TSHB—hypothyroidism	0.000627	0.002	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—TSHR—hypothyroidism	0.000627	0.002	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000605	0.00193	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—TSHR—hypothyroidism	0.000604	0.00193	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—TSHB—hypothyroidism	0.000604	0.00193	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—TRH—hypothyroidism	0.000602	0.00192	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000571	0.00182	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—TSHB—hypothyroidism	0.000569	0.00182	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—TSHR—hypothyroidism	0.000569	0.00182	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—AVP—hypothyroidism	0.00056	0.00179	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—TRH—hypothyroidism	0.000547	0.00175	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—POMC—hypothyroidism	0.000542	0.00173	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—TSHB—hypothyroidism	0.000536	0.00171	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—TSHR—hypothyroidism	0.000536	0.00171	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—TRH—hypothyroidism	0.000531	0.0017	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—TRH—hypothyroidism	0.000523	0.00167	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—TRH—hypothyroidism	0.00052	0.00166	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—AVP—hypothyroidism	0.000494	0.00158	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000488	0.00156	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—TSHB—hypothyroidism	0.000487	0.00156	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—TSHR—hypothyroidism	0.000487	0.00156	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—AVP—hypothyroidism	0.000486	0.00155	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—AVP—hypothyroidism	0.000483	0.00154	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—TRH—hypothyroidism	0.000482	0.00154	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—IYD—hypothyroidism	0.000479	0.00153	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—TRH—hypothyroidism	0.000475	0.00152	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	0.000473	0.00151	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	0.000473	0.00151	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—TRH—hypothyroidism	0.000472	0.00151	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	0.000466	0.00149	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	0.000466	0.00149	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—TSHB—hypothyroidism	0.000463	0.00148	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—TSHR—hypothyroidism	0.000463	0.00148	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CLTC—hypothyroidism	0.000463	0.00148	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—POMC—hypothyroidism	0.000461	0.00147	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CLTC—hypothyroidism	0.000437	0.0014	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—POMC—hypothyroidism	0.000435	0.00139	CbGpPWpGaD
Minaprine—ACHE—Metabolism—TSHB—hypothyroidism	0.000432	0.00138	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000431	0.00138	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—TSHB—hypothyroidism	0.00043	0.00137	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—TSHR—hypothyroidism	0.00043	0.00137	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000424	0.00135	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	0.000423	0.00135	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	0.000423	0.00135	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000422	0.00135	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—TSHR—hypothyroidism	0.000421	0.00134	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—TSHB—hypothyroidism	0.000421	0.00134	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000407	0.0013	CbGpPWpGaD
Minaprine—MAOA—Metabolism—TSHB—hypothyroidism	0.000407	0.0013	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—VAV3—hypothyroidism	0.000407	0.0013	CbGpPWpGaD
Minaprine—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000406	0.0013	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TRH—hypothyroidism	0.0004	0.00128	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AVP—hypothyroidism	0.000392	0.00125	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PIK3C2A—hypothyroidism	0.000385	0.00123	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—VAV3—hypothyroidism	0.000384	0.00123	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TPO—hypothyroidism	0.000383	0.00122	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.00038	0.00121	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TRH—hypothyroidism	0.000377	0.00121	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CLTC—hypothyroidism	0.000374	0.00119	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—POMC—hypothyroidism	0.000372	0.00119	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AVP—hypothyroidism	0.00037	0.00118	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—VAV3—hypothyroidism	0.000369	0.00118	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PIK3C2A—hypothyroidism	0.000363	0.00116	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TSHB—hypothyroidism	0.000357	0.00114	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TSHR—hypothyroidism	0.000357	0.00114	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AVP—hypothyroidism	0.000356	0.00114	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—VAV3—hypothyroidism	0.000348	0.00111	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TSHB—hypothyroidism	0.000336	0.00107	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TSHR—hypothyroidism	0.000336	0.00107	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AVP—hypothyroidism	0.000336	0.00107	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CLTC—hypothyroidism	0.00033	0.00105	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—POMC—hypothyroidism	0.000328	0.00105	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	0.000328	0.00105	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—POMC—hypothyroidism	0.000328	0.00105	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CLTC—hypothyroidism	0.000324	0.00104	CbGpPWpGaD
Minaprine—ACHE—Metabolism—SLC5A5—hypothyroidism	0.000323	0.00103	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TRH—hypothyroidism	0.000323	0.00103	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—POMC—hypothyroidism	0.000323	0.00103	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CLTC—hypothyroidism	0.000323	0.00103	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—POMC—hypothyroidism	0.000321	0.00103	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	0.000318	0.00102	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	0.000316	0.00101	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—IGF1—hypothyroidism	0.000316	0.00101	CbGpPWpGaD
Minaprine—MAOA—Metabolism—SLC5A5—hypothyroidism	0.000305	0.000973	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SH2B3—hypothyroidism	0.0003	0.000958	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	0.000298	0.000952	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	0.00029	0.000925	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TSHB—hypothyroidism	0.000288	0.000919	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TSHR—hypothyroidism	0.000288	0.000919	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AVP—hypothyroidism	0.000287	0.000917	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	0.000285	0.00091	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TRH—hypothyroidism	0.000285	0.00091	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—VAV3—hypothyroidism	0.000283	0.000906	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TRH—hypothyroidism	0.00028	0.000896	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AVP—hypothyroidism	0.000279	0.000891	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TRH—hypothyroidism	0.000279	0.000891	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	0.000275	0.000877	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AVP—hypothyroidism	0.000273	0.000872	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—VAV3—hypothyroidism	0.000263	0.00084	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	0.00026	0.000832	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	0.000259	0.000827	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—VAV3—hypothyroidism	0.000257	0.000822	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	0.000257	0.000819	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TSHR—hypothyroidism	0.000254	0.000811	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TSHB—hypothyroidism	0.000254	0.000811	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AVP—hypothyroidism	0.000253	0.00081	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TSHB—hypothyroidism	0.00025	0.000798	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TSHR—hypothyroidism	0.00025	0.000798	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AVP—hypothyroidism	0.000249	0.000797	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TSHB—hypothyroidism	0.000249	0.000794	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TSHR—hypothyroidism	0.000249	0.000794	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AVP—hypothyroidism	0.000248	0.000792	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—POMC—hypothyroidism	0.000246	0.000785	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—POMC—hypothyroidism	0.000237	0.000756	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PRL—hypothyroidism	0.000236	0.000754	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SH2B3—hypothyroidism	0.000226	0.000723	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—POMC—hypothyroidism	0.000223	0.000713	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	0.000223	0.000712	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PRL—hypothyroidism	0.000222	0.000711	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SH2B3—hypothyroidism	0.000222	0.000708	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VAV3—hypothyroidism	0.000218	0.000697	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AVP—hypothyroidism	0.00021	0.000672	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	0.00021	0.000671	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VAV3—hypothyroidism	0.000206	0.000657	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AVP—hypothyroidism	0.000198	0.000633	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—POMC—hypothyroidism	0.000191	0.00061	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PRL—hypothyroidism	0.00019	0.000608	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—POMC—hypothyroidism	0.000185	0.000592	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	0.000182	0.000583	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—POMC—hypothyroidism	0.000181	0.00058	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TSHB—hypothyroidism	0.000177	0.000566	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VAV3—hypothyroidism	0.000176	0.000562	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AVP—hypothyroidism	0.00017	0.000542	CbGpPWpGaD
Minaprine—ACHE—Metabolism—POMC—hypothyroidism	0.000169	0.000541	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—POMC—hypothyroidism	0.000168	0.000538	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PRL—hypothyroidism	0.000168	0.000537	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—POMC—hypothyroidism	0.000166	0.000529	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PRL—hypothyroidism	0.000165	0.000528	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—POMC—hypothyroidism	0.000165	0.000527	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PRL—hypothyroidism	0.000164	0.000525	CbGpPWpGaD
Minaprine—MAOA—Metabolism—POMC—hypothyroidism	0.000159	0.000509	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	0.000158	0.000505	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VAV3—hypothyroidism	0.000155	0.000496	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VAV3—hypothyroidism	0.000153	0.000488	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VAV3—hypothyroidism	0.000152	0.000486	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AVP—hypothyroidism	0.00015	0.000478	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AVP—hypothyroidism	0.000147	0.000471	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AVP—hypothyroidism	0.000147	0.000468	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—POMC—hypothyroidism	0.00014	0.000446	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IGF1—hypothyroidism	0.000134	0.000429	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	0.000133	0.000424	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—POMC—hypothyroidism	0.000132	0.000421	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IGF1—hypothyroidism	0.000127	0.000405	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—POMC—hypothyroidism	0.000113	0.00036	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IGF1—hypothyroidism	0.000108	0.000346	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—POMC—hypothyroidism	9.95e-05	0.000318	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—POMC—hypothyroidism	9.79e-05	0.000313	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—POMC—hypothyroidism	9.74e-05	0.000311	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF1—hypothyroidism	9.57e-05	0.000306	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF1—hypothyroidism	9.42e-05	0.000301	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF1—hypothyroidism	9.36e-05	0.000299	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—POMC—hypothyroidism	6.94e-05	0.000222	CbGpPWpGaD
